Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Vonoprazan in Barrett's Esophagus
NCT07788742Phase 4Not yet recruiting
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Aug 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vonoprazan in Barrett's esophagus, sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Percent time with pH<4 during 24-hour pH monitoring. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
vonoprazan
03
Conditions
Barrett's esophagus
Beyond the preview
Go deeper on NCT07788742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07788742.